Follow-up | Follow-up | |||
---|---|---|---|---|
Day of screening | Day of operation | Visit 1 (day 30post OP ) by phone | Visit 2-8 (European Pancreas Center) | |
Past medical history* | X | |||
Informed consent | X | |||
Personal data** | X | |||
Examination of primary endpoints: | ||||
Operating time | X | |||
Examination of primary endpoints: | ||||
Mortality | X | X | X | |
Peri- and postoperative complications | X | X | X | |
Re-intervention | X | X | ||
Intraoperative blood loss | X | |||
Hospital stay | X | |||
Reuptake | X | X | ||
Time of anesthesia pre- and postoperative | X | |||
Intraoperative material consumption | X | |||
Local recurrence | X | |||
Quality of life | X | X | ||
Safety criteria AE, SAE (2.6) | X | X | X |